Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Biogen | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Evaluate a method of testing the strength of five key lower limb muscle groups using a hand-held strength gauge (dynamometer).
Purpose of this study is to assess the intra-rater and inter-rater reliability of a hand-held dynamometer (HHD) in the assessment of lower limb strength in patients with Multiple Sclerosis.
Also to establish a standardized strength testing procedure for key lower limb muscle groups using a HHD fo research and clinical purposes in Multiple Sclerosis.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| EDSS Score 0-3.5 | 21 Subjects Total : 7 with normal to mildly limited walking | ||
| EDSS Score 4.0-5.5 | 21 Subjects total: 7 subjects with moderately limited walking ability. | ||
| EDSS Score 6.0-7.5 | 21 Subjects total: 7 subjects with severely limited walking ability |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Assessment of HHD | To assess the intra-rater and inter-rater reliability of a hand-held dynamometer(HHD) in the assessment of lower limb strength in patients with Multiple Sclerosis. To establish a standardized strength testing procedure for key lower limb muscle groups using a HHD for research and clinical purposes in Multiple Sclerosis. | Outcome measures will be assessed once we have captured all data points for all 21 subjects. |
| Measure | Description | Time Frame |
|---|---|---|
| Validation of a Hand-held dynamometer for assessment of lower limb muscle strength. | to establish a standardized strength testing procedure for key lower limb muscle groups using a Hand-held dynamometer for research and clinical purposes in Multiple Sclerosis. | outcome measures will be assessed once we have captured all data points for all 21 subjects |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Stable patients with clinically definite Multiple Sclerosis, aged 18 over, no Multiple Sclerosis exacerbation or change in disease modifying therapy for 30 days prior to screening. Subjects will fall into 1 of 3 EDSS catagories: 0-3.5; 4.0-5.5; 6.0-7.5.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Theodore R Brown, MD | MS Center at Evergreen Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| MS Center at Evergreen Hospital | Kirkland | Washington | 98034 | United States |
Not provided
| ID | Term |
|---|---|
| D009103 | Multiple Sclerosis |
| ID | Term |
|---|---|
| D020278 | Demyelinating Autoimmune Diseases, CNS |
| D020274 | Autoimmune Diseases of the Nervous System |
| D009422 | Nervous System Diseases |
| D003711 | Demyelinating Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |